Table 1 Patient and treatment characteristics
(N = 49) | |
|---|---|
Sex | |
Male | 39 (80%) |
Female | 10 (20%) |
Age at diagnosis (years) | |
Median | 66 |
Range | 52–91 |
T-stage | |
T1 | 3 (6%) |
T2 | 19 (39%) |
T3 | 17 (35%) |
T4 | 10 (20%) |
Subsite primary tumor | |
Oropharynx | 24 (49%) |
Larynx | 17 (35%) |
Hypopharynx | 8 (16%) |
HPV status (oropharynx) | |
Negative | 14 (58%) |
Positive | 10 (42%) |
N-stage | |
N0 | 22 (45%) |
N1 | 11 (22%) |
N2 | 13 (27%) |
N3 | 3 (6%) |
Delineated lymph nodes per neck level | |
Level 1A | 6 (3%) |
Level 1B | 33 (19%) |
Level 2 | 98 (56%) |
Level 3 | 27 (16%) |
Level 4 | 5 (3%) |
Level 5 | 6 (3%) |
Treatment | |
Radiotherapy | 30 (61%) |
Chemoradiotherapy | 19 (39%) |